These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11805587)

  • 21. Parity, age at first childbirth, and risk of ovarian cancer.
    Adami HO; Hsieh CC; Lambe M; Trichopoulos D; Leon D; Persson I; Ekbom A; Janson PO
    Lancet; 1994 Nov; 344(8932):1250-4. PubMed ID: 7967985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico.
    Salazar-Martinez E; Lazcano-Ponce EC; Gonzalez Lira-Lira G; Escudero-De los Rios P; Salmeron-Castro J; Hernandez-Avila M
    Cancer Res; 1999 Aug; 59(15):3658-62. PubMed ID: 10446978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fertility drugs and risk of epithelial ovarian cancer in Italy.
    Franceschi S; La Vecchia C; Negri E; Guarneri S; Montella M; Conti E; Parazzini F
    Hum Reprod; 1994 Sep; 9(9):1673-5. PubMed ID: 7836516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The risk of epithelial ovarian cancer in short-term users of oral contraceptives.
    Gross TP; Schlesselman JJ; Stadel BV; Yu W; Lee NC
    Am J Epidemiol; 1992 Jul; 136(1):46-53. PubMed ID: 1415131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: A nationwide case-control study.
    Rasmussen ELK; Hannibal CG; Dehlendorff C; Baandrup L; Junge J; Vang R; Kurman RJ; Kjaer SK
    Gynecol Oncol; 2017 Mar; 144(3):571-576. PubMed ID: 28108026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for ovarian cancer: a case-control study.
    Booth M; Beral V; Smith P
    Br J Cancer; 1989 Oct; 60(4):592-8. PubMed ID: 2679848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Reproductive activities as risk factors of epithelial ovarian cancer: a case-control epidemiologic study].
    Chen Y
    Zhonghua Fu Chan Ke Za Zhi; 1991 May; 26(3):158-61, 188. PubMed ID: 1874060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reproduction-related risk factors for mucinous and nonmucinous epithelial ovarian cancer.
    Purdie DM; Siskind V; Bain CJ; Webb PM; Green AC
    Am J Epidemiol; 2001 May; 153(9):860-4. PubMed ID: 11323316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "Incessant ovulation" and ovarian cancer.
    Casagrande JT; Louie EW; Pike MC; Roy S; Ross RK; Henderson BE
    Lancet; 1979 Jul; 2(8135):170-3. PubMed ID: 89281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epithelial ovarian cancer and combination oral contraceptives.
    Rosenberg L; Shapiro S; Slone D; Kaufman DW; Helmrich SP; Miettinen OS; Stolley PD; Rosenshein NB; Schottenfeld D; Engle RL
    JAMA; 1982 Jun; 247(23):3210-2. PubMed ID: 7045417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of fertility drugs and risk of ovarian cancer.
    Parazzini F; Pelucchi C; Negri E; Franceschi S; Talamini R; Montella M; La Vecchia C
    Hum Reprod; 2001 Jul; 16(7):1372-5. PubMed ID: 11425815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Events of reproductive life and the incidence of epithelial ovarian cancer.
    Risch HA; Weiss NS; Lyon JL; Daling JR; Liff JM
    Am J Epidemiol; 1983 Feb; 117(2):128-39. PubMed ID: 6681935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Univariate and multivariate analysis of risk factors for ovarian cancer: case-control study, Mexico City.
    Bernal A; Méndez-Moran L; Fajardo-Gutiérrez A; González-Lira G; Escudero P; Ortiz H
    Arch Med Res; 1995; 26(3):245-9. PubMed ID: 8580675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study.
    Risch HA; Marrett LD; Jain M; Howe GR
    Am J Epidemiol; 1996 Aug; 144(4):363-72. PubMed ID: 8712193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Luteinizing hormone, its beta-subunit variant, and epithelial ovarian cancer: the gonadotropin hypothesis revisited.
    Akhmedkhanov A; Toniolo P; Zeleniuch-Jacquotte A; Pettersson KS; Huhtaniemi IT
    Am J Epidemiol; 2001 Jul; 154(1):43-9. PubMed ID: 11427404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cigarette smoking and the risk of epithelial ovarian cancer.
    Franks AL; Lee NC; Kendrick JS; Rubin GL; Layde PM
    Am J Epidemiol; 1987 Jul; 126(1):112-7. PubMed ID: 3591776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral contraceptives, other methods of contraception, and risk reduction for ovarian cancer.
    Ness RB; Grisso JA; Vergona R; Klapper J; Morgan M; Wheeler JE;
    Epidemiology; 2001 May; 12(3):307-12. PubMed ID: 11337604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for ovarian cancer in central Italy.
    Greggi S; Parazzini F; Paratore MP; Chatenoud L; Legge F; Mancuso S; La Vecchia C
    Gynecol Oncol; 2000 Oct; 79(1):50-4. PubMed ID: 11006030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
    Baandrup L
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Body mass index at age 18 years and during adult life and ovarian cancer risk.
    Lubin F; Chetrit A; Freedman LS; Alfandary E; Fishler Y; Nitzan H; Zultan A; Modan B
    Am J Epidemiol; 2003 Jan; 157(2):113-20. PubMed ID: 12522018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.